BioLineRx Ltd. (BLRX.TA)
ILA 1.7
(0.0%)
ILA 1.7
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 50.8 Million USD | 51.25% |
| 2022 | 29.15 Million USD | 17.68% |
| 2021 | 24.77 Million USD | 8.07% |
| 2020 | 22.92 Million USD | -18.44% |
| 2019 | 28.11 Million USD | 9.79% |
| 2018 | 25.6 Million USD | 1.45% |
| 2017 | 25.24 Million USD | 52.85% |
| 2016 | 16.51 Million USD | 1.96% |
| 2015 | 16.19 Million USD | 2.18% |
| 2014 | 15.85 Million USD | -10.08% |
| 2013 | 17.62 Million USD | -19.26% |
| 2012 | 21.83 Million USD | 41.66% |
| 2011 | 15.41 Million USD | -26.56% |
| 2010 | 20.98 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 10.26 Million USD | 0.46% |
| 2024 Q1 | 10.22 Million USD | -21.2% |
| 2023 Q4 | 12.97 Million USD | 4.98% |
| 2023 Q2 | 9.91 Million USD | 11.96% |
| 2023 FY | 44.1 Million USD | 51.25% |
| 2023 Q3 | 12.35 Million USD | 24.63% |
| 2023 Q1 | 8.85 Million USD | 5.45% |
| 2022 Q2 | 7.6 Million USD | 25.05% |
| 2022 Q3 | 7.07 Million USD | -6.89% |
| 2022 Q4 | 8.39 Million USD | 18.65% |
| 2022 FY | 29.15 Million USD | 17.68% |
| 2022 Q1 | 6.07 Million USD | -7.87% |
| 2021 Q1 | 5.44 Million USD | -7.2% |
| 2021 Q2 | 6.51 Million USD | 19.53% |
| 2021 Q4 | 6.59 Million USD | 6.13% |
| 2021 FY | 24.77 Million USD | 8.07% |
| 2021 Q3 | 6.21 Million USD | -4.54% |
| 2020 Q2 | 5.56 Million USD | -18.63% |
| 2020 Q4 | 5.87 Million USD | 26.31% |
| 2020 FY | 22.92 Million USD | -18.44% |
| 2020 Q3 | 4.64 Million USD | -16.48% |
| 2020 Q1 | 6.84 Million USD | -27.33% |
| 2019 Q2 | 6.47 Million USD | 16.12% |
| 2019 Q1 | 5.57 Million USD | -20.73% |
| 2019 FY | 28.11 Million USD | 9.79% |
| 2019 Q3 | 6.64 Million USD | 2.56% |
| 2019 Q4 | 9.41 Million USD | 41.7% |
| 2018 Q2 | 5.72 Million USD | -13.61% |
| 2018 FY | 25.6 Million USD | 1.45% |
| 2018 Q4 | 7.03 Million USD | 13.28% |
| 2018 Q3 | 6.21 Million USD | 8.47% |
| 2018 Q1 | 6.62 Million USD | -13.77% |
| 2017 Q2 | 5.19 Million USD | -2.02% |
| 2017 Q1 | 5.3 Million USD | 20.92% |
| 2017 FY | 25.24 Million USD | 52.85% |
| 2017 Q4 | 7.68 Million USD | 8.94% |
| 2017 Q3 | 7.05 Million USD | 35.87% |
| 2016 Q3 | 4.48 Million USD | 16.09% |
| 2016 FY | 16.51 Million USD | 1.96% |
| 2016 Q1 | 3.77 Million USD | -7.9% |
| 2016 Q2 | 3.86 Million USD | 2.38% |
| 2016 Q4 | 4.38 Million USD | -2.32% |
| 2015 FY | 16.19 Million USD | 2.18% |
| 2015 Q4 | 4.1 Million USD | 13.79% |
| 2015 Q3 | 3.6 Million USD | -13.51% |
| 2015 Q2 | 4.16 Million USD | -3.72% |
| 2015 Q1 | 4.32 Million USD | -2.28% |
| 2014 Q3 | 3.87 Million USD | -1.79% |
| 2014 Q2 | 3.94 Million USD | -3.03% |
| 2014 FY | 15.85 Million USD | -10.08% |
| 2014 Q1 | 4.07 Million USD | 34.3% |
| 2014 Q4 | 4.42 Million USD | 14.21% |
| 2013 Q2 | 4.59 Million USD | -29.31% |
| 2013 Q1 | 6.49 Million USD | -7.03% |
| 2013 Q4 | 3.03 Million USD | -6.63% |
| 2013 FY | 17.62 Million USD | -19.26% |
| 2013 Q3 | 3.24 Million USD | -29.31% |
| 2012 FY | 21.83 Million USD | 41.66% |
| 2012 Q3 | 4.97 Million USD | -2.2% |
| 2012 Q2 | 5.08 Million USD | -0.37% |
| 2012 Q1 | 5.1 Million USD | 21.87% |
| 2012 Q4 | 6.98 Million USD | 40.48% |
| 2011 Q1 | 2.87 Million USD | -48.99% |
| 2011 Q3 | 4.5 Million USD | 2.4% |
| 2011 Q4 | 4.18 Million USD | -7.09% |
| 2011 FY | 15.41 Million USD | -26.56% |
| 2011 Q2 | 4.4 Million USD | 53.28% |
| 2010 Q1 | 3.94 Million USD | 0.0% |
| 2010 Q2 | 7.93 Million USD | 101.39% |
| 2010 Q3 | 2.93 Million USD | -63.01% |
| 2010 Q4 | 5.63 Million USD | 91.75% |
| 2010 FY | 20.98 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Matricelf Ltd | 11.78 Million ILA | -331.073% |